ArticleBreast cancer research : BCR2016

Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.

Sabine Kasimir-Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.